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A B S T R A C T
Aquaculture, the fastest growing food production sector cannot continue to rely on finite stocks of marine fish as
the primary source of the omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic
acid (EPA; 20:5n3) and docosahexaenoic acid (DHA; 22:6n-3), for feeds. A four-month feeding trial was con-
ducted to investigate the impact of a de novo oil, with high levels of EPA and DHA, obtained from transgenic
Camelina sativa on growth performance, tissue fatty acid profiles, and expression of lipid metabolism genes when
used as a replacement for fish oil in feed for European seabass (Dicentrachus labrax). Triplicate groups of 50
juvenile fish (initial weight 16.7 ± 0.92 g) per tank were fed for 4 months with one of three isolipidic and
isoproteic experimental diets consisting of a standard diet containing a commercial blend of fish oil and rapeseed
oil (CFO), a diet containing transgenic Camelina oil (TCO), or a blend of fish oil and rapeseed oil with enhanced
levels of EPA and DHA (EFO) formulated to match the n-3 LC-PUFA profile of the TCO feed. Final weight of fish
fed the GM-derived oil was not different to fish fed either CFO or EFO. Slight lower growth performance of fish
fed TCO at the beginning of the trial was related to transient reduced feed intake, possibly caused by glucosi-
nolates in the raw Camelina sativa oil. The GM-derived oil improved the nutritional quality of the fish fillet by
enhancing total n-3 PUFA levels compared to the fish fed the other two feeds, and maintained flesh EPA and DHA
at the same levels as in fish fed the diets containing fish oil. The metabolic response in liver and intestine was
generally relatively mild although diets TCO and EFO seemed to trigger a metabolic response consisting of an up-
regulation of both β-oxidation (cpt1a) and fatty acid transport (fabp1), possibly reflecting higher levels of LC-
PUFA. Overall, the present study indicated that an oil of terrestrial origin, Camelina sativa, when engineered to
contain high levels of EPA and DHA can replace fish oil in feeds for European seabass with no detrimental impact
on growth or feed efficiency, while also maintaining or increasing tissue n-3 LC-PUFA contents.
1. Introduction
Fish are the primary dietary source of n-3 LC-PUFA for humans,
where eicosapentaenoate (EPA; 20:5n-3) and docosahexaenoate (DHA;
22:6n-3) in particular have been recognized to provide health benefits
(Calder, 2018; Shahidi and Ambigaipalan, 2018; Innes and Calder,
2020). However, LC-PUFA are also essential nutrients for many fish
species (GOED, 2020; Tocher et al., 2019). In vertebrates, EPA, DHA,
and arachidonic acid (ARA; 20:4n-6) can be synthesized by the se-
quential desaturation and elongation of α-linolenic acid (ALA; 18:3n-3)
and linoleic acid (LA; 18:2n-6), respectively (Salem et al., 1996;
Sprecher et al., 1995). However, the rate of biosynthesis is usually very
low and so in vivo production of EPA and DHA is limited in most ver-
tebrates (Tocher et al., 2019). The primary producers of n-3 LC-PUFA
are microalgae that are able to directly synthesize EPA and DHA, which
are then accumulated up the marine food chain to fish through the
consumption of phytoplankton and zooplankton (Harris, 2010). For this
reason, fish and seafood are the primary sources of n-3 LC-PUFA in the
human diet (GOED, 2020). A daily dose of 500 mg of EPA + DHA is
recommended for optimal health in humans, which requires consuming
at least two portions of fish per week (GOED, 2020).
Farmed fish also require EPA and DHA supplied in the diet to ensure
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adequate growth and health, but also to accumulate n-3 LC-PUFA in
order to pass on to human consumers. Traditionally this was ensured by
including the marine ingredients, fishmeal (FM) and fish oil (FO), in
feeds. However, FM and FO are finite and limited resources, which
limits the supply of EPA and DHA to aquaculture (Tocher et al., 2019).
Thus, as the main user and provider of n-3 LC-PUFA, the aquaculture
industry has been a central driver in research aiming to alleviate the
global shortfall in these key nutrients (Betancor et al., 2017; Tocher
et al., 2019). Thus, as the industry grows and develops more sustainable
practices, marine ingredients have been increasingly replaced in feeds
by increasing proportions of terrestrial plant-based ingredients that lack
LC-PUFA (Tocher, 2015).
While finding viable alternatives using new, de novo sources of LC-
PUFA with appropriate inclusion of DHA and EPA is inherently com-
plex, it is also highly necessary. Alternative lipid sources of marine
origin can offer comparable nutrient profiles to FO, however most
fisheries are already operating at or above sustainable harvest limits
(FAO, 2018). Biotechnological initiatives to mass produce microalgae
or zooplankton (krill and copepods) have been suggested as sustainable
alternatives, but the actuality remains restricted largely by technolo-
gical and (predominantly) economic challenges (Sprague et al., 2017;
Tocher et al., 2019; Fabris et al., 2020). Incorporation of alternatives
such as vegetable and rendered oils into feeds has led to dietary dilution
of n-3 LC-PUFA, as well as an increase in the amount of n-6 PUFA
(Glencross, 2009; Sprague et al., 2016).
Metabolic engineering of oilseed crops, specifically Camelina sativa
or false flax is a feasible solution to meet n-3 LC-PUFA requirements in
replacing fish oil (Haslam et al., 2015). Production of C. sativa con-
taining n-3 LC-PUFA was accomplished by inserting seven fatty acyl
desaturase and elongase genes from various marine microalgae species,
resulting in genetically-modified (GM) Camelina plants capable of pro-
ducing EPA and DHA (Ruiz-Lopez et al., 2014). Trials using GM Ca-
melina in Atlantic salmon (Salmo salar) and gilthead sea bream (Sparus
aurata) as a replacement for FO have shown no negative effects on
growth performance, while enhancing accumulation and deposition of
n-3 LC-PUFA compared to non-GM vegetable oil alternatives (Betancor
et al., 2015a, 2015b, 2016a, 2016b, 2017, 2018). Such findings are
promising as they demonstrate the success of GM Camelina in restoring
EPA and DHA in farmed fish to the levels found prior to the application
of sustainable feeds (Sprague et al., 2016; Tocher et al., 2019).
The present study aimed to evaluate the effectiveness of oil from GM
Camelina sativa as a dietary source of EPA and DHA in feeds for
European seabass (Dicentrarchus labrax), a non-oily marine teleost
species with limited LC-PUFA biosynthesis capacity. The trial compared
sea bass fed the transgenic Camelina oil (TCO; EPA + DHA at 15.5%
total fatty acids) with fish fed a commercial feed formulation containing
FO and rapeseed oil (CFO; EPA + DHA at 11.7% total fatty acids), and
an enhanced fish and rapeseed oil blend (EFO; EPA + DHA at 14.2%
total fatty acids). Specific objectives were to evaluate the effects of
transgenic Camelina oil in feeds on growth performance, feed effi-
ciency, tissue fatty acid profiles and the expression of lipid-related
genes in liver.
2. Materials and methods
2.1. Diets and feeding trial
Three isolipidic and isoproteic diets were formulated with different
lipid sources and, therefore, different fatty acid profiles (Table 1). Diets
were manufactured at the BioMar Tech Centre (Brande, Denmark) by
vacuum coating identical dry basal extruded pellets with either FO and
rapeseed oil in a commercial-like blend (CFO), transgenic Camelina oil
(TCO; EPA 8.2%, DPA 5.7%, DHA 7.4% of total fatty acids), or an en-
hanced FO and rapeseed oil blend (EFO) to provide similar EPA and
DHA levels to the TCO diet (Table 1). Details about the production of
the GM-derived oil have been described previously (Ruiz-Lopez et al.,
2014). A total of 450 juvenile European seabass with an average initial
body weight of 16.7 ± 0.9 g (mean ± SD) were distributed into nine
seawater tanks (50 fish per tank) and fed one of three experimental
diets in triplicate for 125 days (approximately 4 months). The experi-
mental setup used 500 L tanks supplied with flow-through seawater at
ambient temperature (20 ± 1 °C) and a salinity of 34 g L−1. All fish
were fed until apparent satiation, with feed intake (FI) determined as
the difference between the amount of feed provided minus the amount
of uneaten feed that was collected daily. All procedures were conducted
in accordance with the regulations set forward by the Spanish RD 53/
2013 (BOE 8th February 2013) and Directive 2010/63/EU of the Eur-
opean Parliament, and of the Council of 22 September 2010 on the
protection of animals used for scientific purposes. Additionally, the
experimental protocol was approved both by the Bioethical Committee
of the University of Las Palmas de Gran Canaria (DGG.364.OEBA) and
the Animal Welfare and Ethical Review Board at the University of
Stirling (AWERB/1617/238).
2.2. Sample collection
Fish were fed for 4 months, with weight and length of all individual
fish measured monthly. All fish were humanely euthanized at the end of
the trial with an overdose of anaesthetic (2-phenoxyethanol; 8 mL/L),
with the last feed provided 48 h prior to culling. Two whole fish per
tank were immediately frozen at −70 °C and later homogenized,
Table 1
Formulations (%) of the experimental feeds.
CFO TCO EFO
Feed ingredients (%)
Fish meal, BioMar A/S 25.0 25.0 25.0
Soya, non-GM SPC 7.5 7.5 7.5
Rapeseed meal 5.0 5.0 5.0
Sunflower meal 5.9 5.7 5.7
Wheat gluten 2.0 2.0 2.0
Maize gluten 15.1 15.2 15.2
Guar meal 7.5 7.5 7.5
Wheat 16.3 16.1 16.1
Fish oil 5.7 – 7.6
Rapeseed oil 7.2 – 5.6
Camelina oil (transgenic) – 13.6 –
Premix 2.4 2.4 2.4
Yttrium oxide 0.05 0.05 0.05
Analyzed composition (%)
Dry matter 92.0 92.1 92.0
Crude protein 41.4 41.8 41.7
Crude lipid 17.5 18.6 17.7
Ash 7.6 7.6 7.6
Fatty acid composition (% fatty acids)
Total saturated1 19.2 16.1 20.6
Total monoenes2 43.7 24.0 39.9
18:2n-6 15.0 21.6 14.4
18:3n-6 0.1 1.6 0.1
20:4n-6 0.5 2.2 0.6
Total n-6 PUFA3 15.9 27.4 15.5
18:3n-3 5.3 9.0 4.6
20:5n-3 6.5 8.2 8.1
22:5n-3 0.9 3.8 1.1
22:6n-3 5.2 7.3 6.1
Total n-3 PUFA4 19.5 32.1 21.9
Total n-3 LC-PUFA 12.9 21.0 15.7
EPA/DHA 1.2 1.1 1.3
CFO, commercial fish and vegetable oil feed; EFO, enhanced fish and vegetable
oil feed; LC-PUFA, long-chain polyunsaturated fatty acid; TCO, transgenic
Camelina oil feed.
1 Includes14:0, 15:0, 16:0, 18:0, 20:0, 22:0, 24:0.
2 Includes 16:1n-9, 16:1n-7, 17:1, 18:1n-9, 18:1n-7, 20:1n-11, 20:1n-9,
20:1n-7, 22;1n-11, 22:1n-9, 24:1n-9.
3 Includes 20:2n-6, 20:3n-6; 22:4n-6, 22:5n-6.
4 Includes 18:4n-3, 20:3n-3, 20:4n-3.
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pooled per tank (n = 3) and freeze-dried prior to analysis of proximate
composition. Liver and anterior intestine were aseptically removed
from an additional four fish per tank and stabilized immediately in
RNAlater (Sigma, Poole, UK). The samples were then maintained at 4 °C
overnight before being stored at −20 °C prior to RNA extraction.
Samples of brain, liver, intestine, gill, head kidney and muscle were
collected from a further two fish per tank, and were immediately frozen
at −70 °C prior to lipid and fatty acid analyses. Additionally, blood
from 3 fish per tank (n = 9) was collected via the caudal vein by 1 mL
heparinized syringes fitted with 18 G needles, transferred to 1.5 mL
tubes and centrifuged at 1000g for 20 min to allow red blood cells
(RBC) to separate before the RBC pellet was quickly frozen at −70 °C
prior to fatty acid analyses.
2.3. Calculations
Biometric parameters were calculated as follows: Specific growth
rate (SGR) = 100 × (LnWf − LnWo) × D−1, where Wo is the initial
stocking weight of fish, Wf is the final sampling weight, and D is the
number of days in the trial (D = 125). Feed conversion ratio
(FCR) = (F/N/D)/(Wg/D), where F is the total feed consumed, N is the
number of fish, D is the number of days in the trial, and Wg is the weight
gain (Wf − Wo). Fulton's condition factor (k) = 100 × (Wf/L3), where
Wf is the final weight (g) and L is the total length (cm). Feed intake (FI;
%BW day−1) = FI/BWmean × 100, where FI (g/day) is the average feed
intake per fish per day and BWmean is the mean body weight, which was
calculated as BWmean (g) = (Wf + Wo)/2. Hepatosomatic index
(HSI) = (Wl/Wf) × 100, where Wl is the weight of the liver, and Wf is
the final weight of fish. Visceral somatic index (VSI) = (Wv/Wf) × 100,
where Wv is the weight of all viscera, and Wf is the final weight of fish.
Fat-somatic index (FSI) = (Wfat/Wf) × 100, where Wfat is the weight of
all fat, and Wf is the final weight of fish.
2.4. Proximate composition
Two whole fish per tank were ground, freeze-dried and prepared as
pooled homogenates (n = 3) prior to analyses of proximate composi-
tion (AOAC, 2010). Crude protein was determined by the Kjeldalh
method using nitrogen content of sample (N × 6.25) with automated
analysis (Tecator Kjeltec Auto 1030 analyser, Foss, Warrington, UK).
Crude lipid content was determined by extracting total lipid followed
by gravimetric quantitation (Folch et al., 1957). Moisture content was
determined following drying in an oven at 110 °C for 24 h (AOAC,
2010). Ash content was determined following incineration in a muffle
furnace at 600 °C for 24 h, all as per standardized procedures.
2.5. Tissue lipid content and fatty acid composition
Total lipid contents of tissues were determined after lipid extraction
by homogenization in chloroform/methanol (2:1, by vol.) using an
Ultra-Turrax tissue disrupter (Fisher Scientific, Loughborough, UK)
following which lipid content was determined gravimetrically (Folch
et al., 1957). Total lipids were resuspended in chloroform/methanol
(2:1) + 0.01% (w/v) BHT to a concentration of 10 mg/mL for sub-
sequent analyses. Fatty acid methyl esters (FAME) of total lipid were
prepared by acid-catalyzed transesterification at 50 °C for 16 h
(Christie, 1993). Fatty acid compositions were determined by gas liquid
chromatography using a Fisons GC-8160 (Thermo Scientific, Milan,
Italy). Chromcard for Windows (version 2.01; Thermoquest Italia
S.p.A., Milan, Italy) was used to collect and process data, and fatty acids
identified using known standards and data obtained from literature
(Ackman, 1980; Tocher and Harvie, 1988).
For RBC, fatty acid composition was determined by direct methy-
lation method. Approximately 100 μL of defrosted RBC was spotted
onto Whatman 903 blood collection cards (GE Healthcare Ltd., Forest
Farm Industrial Estate, Cardiff, UK) and air dried. The RBC sample was
detached with forceps and placed into a screw-cap vial containing 1 mL
of methylating solution (1.25 M HCl/methanol) and then incubated in a
hot block at 70 °C for 1 h. The vials were allowed to cool to room
temperature before adding 2 mL of distilled water and 2 mL of saturated
KCl solution and FAME extracted using 2 mL of isohexane + BHT
followed by a second extraction using 2 mL of isohexane alone. FAME
were separated and quantified by gas liquid chromatography as above.
2.6. RNA extraction and quantitative PCR (qPCR)
Samples of liver and anterior intestine from four fish per tank were
homogenized in TriReagent® (Sigma-Aldrich, Dorset, UK) using a bead
tissue disruptor (Bio Spec, Bartlesville, Oklahoma, USA). Total RNA was
isolated using organic extraction, and quantity and quality determined
by spectrophotometry using a Nanodrop ND-1000 (Labtech Int., East
Sussex, UK) and electrophoresis using 200 ng of total RNA in a 1%
agarose gel. RNA was pooled (6 μg of total RNA per fish) from two fish
per tank for each tissue, thereby producing six pools (n = 6, 2 pools per
tank) per dietary treatment with concentration of pools determined by
spectrophotometry (Nanodrop). cDNA was synthesized using 2 μg of
total RNA and random primers in 10 μL reactions. The resulting cDNA
was diluted 20-fold with milliQ water.
Expression of genes of interest (Supplementary Table S1) was de-
termined by quantitative PCR using a Biometra TOptical Thermocycler
(Analytik Jena, Goettingen, Germany) using 96-well plates in duplicate
10 μL reaction volumes containing 1 μL of the primer (Table 3) corre-
sponding to the analyzed gene (10 pmol/ μL), 1.5 μL of miliQ water,
5 μL SYBR Green Real-Time PCR Master Mix and 2.5 μL of cDNA, with
the exception of the house-keeping genes, which were determined using
2 μL of cDNA. Negative controls (NTC, non template control and RT-,
reverse transcriptase minus) containing no cDNA were also included.
Standard amplification included a UDG (Uracil-DNA glycosylases) pre-
treatment for 2 min at 50 °C, initial denaturation for 10 min at 95 °C,
proceeded by 35 cycles: 15 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C.
After which the melting curve was added (60–95 °C).
Results were normalized for liver and anterior intestine using
housekeeping genes ef1α (M-values of 0.473 and 0.319, respectively),
bactin (M-values of 0.473 and 0.319, respectively), and rplp0 (M-values
of 0.565 and 0.375, respectively) whose expression did not vary among
treatments. The efficiency of the primers for each gene was evaluated
by serial dilutions to ensure that it was close to 100%, quantified using
a standard curve. Stability of housekeeping genes was determined in-
dependently for liver and anterior intestine samples using Genorm (Xie
et al., 2012).
2.7. Statistical analysis
All data were presented as means ± standard deviation (SD; n= 3;
n = 9 for RBC), except for the qPCR analysis that are shown as
means ± standard error (SE; n = 6), with all statistical analyses
performed using SPSS software (IBM SPSS Statistics 19; SPSS Inc.,
Chicago, IL, USA). Arcsine transformation was applied to percentage
data to ensure binomial distribution. Differences between mean values
were analyzed by t-test and one-way analysis of variance (ANOVA)
followed, when pertinent, by a multiple comparison test (Tukey).
Differences rejecting the null hypothesis were reported as statistically
significant when P < .05. The Pfaffl method, which accounts for dif-
ferences in efficiencies, was then used to calculate the relative gene
expression (gene expression fold changes) among treatments (Pfaffl
et al., 2002).
3. Results
3.1. Fish performance and proximate composition
All experimental diets were well accepted by the fish and all
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treatment groups increased in weight by approximately six-fold by the
end of the four-month trial (Table 2). Survival was unaffected by
dietary treatment (not shown). Although no significant differences were
observed, fish fed the EFO diet had the highest final weight, final length
and weight gain, but specific growth rate (SGR) was significantly higher
in fish fed diet EFO compared to fish fed TCO, with fish fed CFO dis-
playing intermediate values (Table 2). Feed intake and feed conversion
ratio were not affected by diet, and no significant differences were
observed in condition factor k, or hepatosomatic (HSI), viscerosomatic
(VSI) and fat-somatic (FSI) indices.
When the performance data were split into the four different sam-
pling points, fish fed CFO displayed the highest SGR and TCO the
lowest, with EFO-fed fish showing intermediate values at the first
sampling point (Fig. 1). Additionally, fish fed TCO showed the lowest
feed intake (FI) at the first sampling point, whereas this parameter was
not different among the experimental groups afterwards (Fig. 1). Diet
had no effect on the biochemical composition of whole fish with no
significant differences in protein, lipid, ash and moisture contents (Data
not shown).
3.2. Tissue lipid contents and fatty acid compositions
3.2.1. Liver
Lipid content of liver varied between 19.1 and 24.7% and, although
there was a trend for higher lipid content in liver of sea bass fed diet
EFO, this was not significant (p = .351; Table 3). Total n-3 PUFA and
LC-PUFA were higher in liver of fish fed diet TCO with the differences
being also significant for EPA, 20:4n-3 and ALA compared to fish fed
either CFO or EFO (Table 3). Total n-6 PUFA was also highest in liver of
fish fed TCO and, while all individual n-6 PUFA were higher in fish fed
TCO, it was only significant with 18:2n-6, 18:3n-6, 20:2n-6 and ARA.
Balancing these effects on PUFA, total monoenes were significantly
lower in liver of sea bass fed diet TCO mainly due to a lower level of
18:1n-9, whereas there were no major significant effects on other sa-
turated fatty acids.
3.2.2. Muscle (flesh)
Lipid content of sea bass muscle (flesh) was relatively low at around
4% with no significant effect of diet (Table 4). Total n-3 PUFA were
significantly higher in muscle of fish fed diet TCO with significant
differences for 20:4n-3 and 22:5n-3, whereas there were no differences
in muscle EPA and DHA or total n-3 LC-PUFA in fish fed the different
diets (Table 4). Total n-6 PUFA was also highest in muscle of fish fed
diet TCO with almost all n-6 PUFA being higher but especially 18:2n-6.
As with liver, the increased PUFA in muscle was balanced by lower
proportions of monoenes, particularly 18:1n-9 and 16:1n-7. Although
percentages of 14:0 and 16:0 were lower in fish fed diet TCO, diet had
no significant effect on total saturates in sea bass flesh.
3.2.3. Red blood cells
Fish fed the TCO diet showed the highest percentages of 18:3n-3,
20:4n-3 and 22:5n-3, but there were no significant differences in the
relative proportions of the other n-3 fatty acids. Fish fed diet TCO
displayed higher proportions of total and all individual n-6 PUFA, apart
from 22:5n-6, than fish fed the other diets. In contrast, the percentages
of total monoenes in red blood cells were significantly lower in fish fed
the TCO diet compared to those fed the other diets, whereas saturated
fatty acids were largely unaffected by diet.
3.2.4. Brain
Lipid content of brain was on average around 10% but there were
no significant differences due to diet (Table 6). Brain was characterized
by a much higher proportion of DHA compared to the other tissues.
However, there were no significant differences in the proportions of n-3
PUFA, LC-PUFA, or individual n-3 fatty acids in brain of fish fed the
different diets. However, fish fed diet TCO had a higher proportion of
ARA compared to fish fed the other diets. As with liver and muscle, total
monoenes were significantly lower in brain of sea bass fed diet TCO
compared to the other diets, whereas total saturates were unaffected by
diet.
3.2.5. Gills
The lipid content of gills varied between 7 and 8% with no sig-
nificant differences due to diet (Table 6). The proportions of all n-3
fatty acids, as well as those of total n-3 PUFA and LC-PUFA, were sig-
nificantly higher in gills of sea bass fed diet TCO compared to fish fed
the other diets, albeit not different to that of EFO-fed fish in the case of
Table 2
Growth performance, survival, feed utilization and whole body biochemical
composition of European seabass after four months of feeding the experimental
diets.
CFO TCO EFO
Initial weight (g) 16.6 ± 1.0 16.7 ± 0.9 16.7 ± 0.9
Final weight (g) 100.8 ± 18.5 98.9 ± 16.9 107.0 ± 19.0
Initial length (cm) 10.5 ± 0.3 10.6 ± 0.4 10.5 ± 0.4
Final length (cm) 18.7 ± 1.2 18.7 ± 1.2 19.0 ± 1.1
Weight gain (g) 84.2 ± 2.9 82.2 ± 4.0 90.3 ± 3.5
HSI 2.0 ± 0.4 1.8 ± 0.4 1.8 ± 0.3
VSI 5.9 ± 1.7 5.5 ± 0.6 5.6 ± 1.0
FSI 6.5 ± 1.7 5.2 ± 0.9 7.8 ± 1.6
FI (kg/tank) 5.29 ± 0.13 4.99 ± 0.24 5.47 ± 0.22
FI (%BW day−1) 1.76 ± 0.05 1.68 ± 0.09 1.82 ± 0.04
FCR 1.3 ± 0.1 1.2 ± 0.1 1.2 ± 0.1
SGR 1.44 ± 0.35ab 1.42 ± 0.30b 1.50 ± 0.33a
k 1.4 ± 0.1 1.4 ± 0.1 1.3 ± 0.1
Whole body composition (% wet weight)
Moisture 62.2 ± 0.3 63.3 ± 1.3 62.4 ± 1.2
Crude protein 24.3 ± 1.9 25.0 + 2.4 23.8 ± 1.7
Crude lipid 10.0 ± 0.8 8.7 ± 1.6 10.2 ± 1.2
Ash 3.5 ± 0.9 3.6 ± 0.7 3.1 ± 0.3
Results are means ± SD (n = 3). Different superscript letters within a row
denote significant differences between diets as determined by one-way ANOVA
with Tukey and Duncan's comparison test (P < .05). CFO, commercial fish and
vegetable oil feed; EFO, enhanced fish and vegetable oil feed; FCR, feed con-
version ratio; FSI, fat-somatic index; BW, body weight; HSI, hepatosomatic
index; k, condition factor; SGR, specific growth rate; TCO, transgenic camelina
oil feed; VSI, viscerosomatic index.
Fig. 1. Effect of diet on feed intake (FI) and specific growth rate (SGR)
throughout the nutritional trial. Depicted are the four sampling points at 33, 63,
94 and 125 days from the initiation of the feeding trial. The grey line corre-
sponds to feed FI and the black line to SGR. Asterisks denote differences in the
evaluated parameters as determined by one-way ANOVA. Diets contained ei-
ther commercial fish oil (CFO), transgenic Camelina sativa oil (TCO), or fish oil
at an enhanced DHA and EPA level (EFO).
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18:4n-3 and EPA and DHA (Table 5). Total n-6 PUFA was also highest in
gill of fish fed TCO due to significantly higher proportions of all in-
dividual n-6 fatty acids other than 22:5n-6. As with the other tissues
above, the higher proportions of PUFA in gills of fish fed diet TCO were
balanced by significantly lower proportions of monoenes, while satu-
rated fatty acids were not significantly affected by diet.
3.2.6. Anterior intestine
The lipid content of anterior intestine of sea bass was not sig-
nificantly affected by diet and varied between 5.6 and 7.2% (Table 7).
The proportions of total n-3 PUFA and LC-PUFA, including EPA and
DHA, were significantly higher in anterior intestine of fish fed diet TCO
compared to fish fed the CFO diet, with levels in fish fed the EFO diet
being generally intermediate (Table 7). Total n-6 PUFA was also highest
in anterior intestine of fish fed TCO due to significantly higher pro-
portions of both ARA and 18:2n-6. Monoenes in anterior intestine
showed the opposite pattern to PUFA and, therefore, the proportion of
monoenes was highest in fish fed diet TCO, lowest in fish fed CFO, and
intermediate in fish fed EFO. The proportion of saturated fatty acids
was higher in anterior intestine of sea bass fed diet EFO compared to
fish fed the other two diets.
3.2.7. Head kidney
The lipid content of head kidney was over 13% in fish fed CFO and
was significantly lower (< 10%) in sea bass fed the TCO and EFO diets
(Table 7). Total n-3 PUFA and LC-PUFA were numerically higher in
liver of fish fed diet TCO compared to fish fed the other feeds, but there
were no significant differences (Table 7). Total n-6 PUFA was also
highest in the head kidney of fish fed TCO due mainly to higher pro-
portions of 18:2n-6 and ARA. Balancing these dietary effects on PUFA,
total monoenes were significantly lower in head kidney of sea bass fed
diet TCO compared to fish fed the other diets, whereas there was sig-
nificant effect of diet on total saturates.
3.3. Liver and anterior intestine gene expression
3.3.1. LC-PUFA biosynthetic genes
No significant differences were found in fatty acid desaturase 2
(fads2) expression in liver (Fig. 2A) or anterior intestine (Fig. 2B). On
the contrary, dietary regulation of fatty acid elongase 5 (elovl5) ex-
pression was observed in both the liver (Fig. 2C) and anterior intestine
(Fig. 2D) being up-regulated in fish fed EFO and TCO, respectively.
3.3.2. Lipid metabolism genes
The expression of the mitochondrial enzyme carnitine palmitoyl-
transferase 1A (cpt1a) was up-regulated in the liver of EFO-fed fish
compared to fish fed the commercial standard diet (Fig. 3A). No sig-
nificant differences were found in cpt1a expression in anterior intestine,
although there was a similar non-significant trend to liver with
Table 3
Total lipid content (% of wet weight) and total lipid fatty acid composition (%
total fatty acids of liver of European seabass after 4 months of feeding the ex-
perimental diets.
CFO TCO EFO
Lipid content 20.3 ± 5.2 19.1 ± 2.8 24.7 ± 5.1
14:0 2.1 ± 0.1 1.8 ± 0.2 2.0 ± 0.3
16:0 23.8 ± 2.8 21.4 ± 4.3 23.4 ± 0.7
18:0 5.6 ± 0.8 5.9 ± 1.4 7.0 ± 1.4
20:0 0.2 ± 0.0b 0.5 ± 0.1a 0.2 ± 0.0b
Total saturated1 32.1 ± 3.5 30.0 ± 5.2 32.9 ± 0.8
16:1n-7 4.8 ± 0.4 3.8 ± 0.7 4.4 ± 0.5
18:1n-9 40.8 ± 0.7ab 33.7 ± 4.9b 42.9 ± 2.4a
18:1n-7 2.9 ± 0.2a 2.3 ± 0.3b 2.9 ± 0.2a
20:1n-11 0.6 ± 0.7 0.1 ± 0.0 0.2 ± 0.0
20:1n-9 1.0 ± 0.8 2.5 ± 0.5 1.2 ± 0.2
20:1n-7 0.1 ± 0.1 0.1 ± 0.0 0.1 ± 0.0
22:1n-11 0.5 ± 0.0 0.4 ± 0.1 0.4 ± 0.1
22:1n-9 0.2 ± 0.0b 0.3 ± 0.1a 0.2 ± 0.0b
24:1n-9 0.3 ± 0.0 0.4 ± 0.1 0.3 ± 0.1
Total monoenes2 52.1 ± 0.5a 44.6 ± 4.2b 53.6 ± 1.6a
18:2n-6 5.9 ± 1.3ab 8.6 ± 2.7a 4.6 ± 0.8b
18:3n-6 0.4 ± 0.1b 1.1 ± 0.3a 0.4 ± 0.1b
20:2n-6 0.3 ± 0.1b 0.6 ± 0.2a 0.2 ± 0.1b
20:3n-6 0.1 ± 0.0 0.3 ± 0.1 0.0 ± 0.0
20:4n-6 0.4 ± 0.1b 1.3 ± 0.6a 0.3 ± 0.1b
22:5n-6 0.1 ± 0.0 0.0 ± 0.1 0.1 ± 0.0
Total n-6 PUFA3 7.0 ± 1.4ab 12.1 ± 3.4a 5.6 ± 1.0b
18:3n-3 1.6 ± 0.5b 3.0 ± 0.5a 1.2 ± 0.2b
18:4n-3 0.5 ± 0.1 0.7 ± 0.1 0.5 ± 0.1
20:3n-3 0.1 ± 0.0 0.3 ± 0.1 n.d.
20:4n-3 0.1 ± 0.0b 0.6 ± 0.2a 0.1 ± 0.0b
20:5n-3 2.6 ± 0.6b 3.7 ± 0.9a 2.6 ± 0.5b
22:5n-3 0.4 ± 0.2b 1.7 ± 0.5a 0.4 ± 0.1b
22:6n-3 3.1 ± 0.6b 5.4 ± 1.3a 2.8 ± 0.3b
Total n-3 PUFA4 8.5 ± 2.0b 15.4 ± 3.6a 7.5 ± 1.2b
Total n-3 LC-PUFA 6.3 ± 1.4b 11.7 ± 3.0a 5.9 ± 0.9b
Results are means ± SEM (n = 3). Different superscript letters within a row
denote significant differences between diets as determined by one-way ANOVA
with Tukey and Duncan's comparison test (P < .05). CFO, commercial fish and
vegetable oil feed; EFO, enhanced fish and vegetable oil feed; PUFA, poly-
unsaturated fatty acids; TCO, transgenic Camelina oil feed.
1 Contains 15:0, 22:0, 24:0.
2 Contains 16:1n-9.
3 Contains 20:3n-6, 22;4n-6.
4 Contains 20:3n-3.
Table 4
Lipid content (% of wet weight) and total lipid fatty acid composition (% total
fatty acids of muscle (flesh) of European seabass after 4 months of feeding the
experimental diets.
CFO TCO EFO
Lipid content 3.7 ± 0.3 4.3 ± 0.9 3.8 ± 1.6
14:0 2.5 ± 0.1a 1.5 ± 0.2b 2.8 ± 0.5a
16:0 16.0 ± 0.6a 14.5 ± 0.3b 15.9 ± 0.5a
18:0 4.0 ± 0.5 4.3 ± 0.1 3.7 ± 0.4
Total saturated1 23.2 ± 1.0 21.4 ± 0.3 23.2 ± 0.5
16:1n-7 3.9 ± 0.1a 2.6 ± 0.2b 4.3 ± 0.4a
18:1n-9 31.6 ± 1.0a 22.1 ± 1.1b 29.7 ± 2.8a
18:1n-7 2.9 ± 0.0 2.2 ± 0.1 2.9 ± 0.2
20:1n-9 1.8 ± 0.0 3.5 ± 0.4 2.1 ± 0.3
22:1n-11 1.0 ± 0.1a 0.8 ± 0.1b 1.0 ± 0.1a
Total monoenes2 42.8 ± 0.8 32.8 ± 1.1 41.6 ± 3.2
18:2n-6 11.3 ± 0.5b 15.6 ± 0.8a 11.7 ± 0.7b
18:3n-6 0.2 ± 0.0 1.1 ± 0.2 0.3 ± 0.1
20:2n-6 0.4 ± 0.0 0.9 ± 0.1 0.5 ± 0.1
20:3n-6 0.1 ± 0.0b 0.4 ± 0.0a 0.1 ± 0.1b
20:4n-6 0.7 ± 0.0 1.9 ± 0.1 0.7 ± 0.3
22:5n-6 0.2 ± 0.0a 0.1 ± 0.0b 0.2 ± 0.0a
Total n-6 PUFA3 13.0 ± 0.5b 20.3 ± 1.1a 13.6 ± 1.2b
18:3n-3 3.6 ± 0.2 5.6 ± 0.4 3.7 ± 0.3
18:4n-3 0.8 ± 0.1 0.9 ± 0.1 0.9 ± 0.1
20:3n-3 0.1 ± 0.0b 0.5 ± 0.1a 0.1 ± 0.1b
20:4n-3 0.3 ± 0.0b 1.1 ± 0.1a 0.4 ± 0.1b
20:5n-3 6.3 ± 0.1 6.4 ± 0.2 6.7 ± 0.4
22:5n-3 0.8 ± 0.3b 2.6 ± 0.2a 1.2 ± 0.3b
22:6n-3 8.0 ± 0.7 7.9 ± 0.4 7.1 ± 1.5
Total n-3 PUFA4 20.1 ± 1.2b 25.1 ± 0.6a 20.4 ± 2.4b
Total n-3 LC-PUFA 15.7 ± 1.0 18.6 ± 0.5 15.8 ± 2.3
Results are means ± SEM (n = 3). Different superscript letters within a row
denote significant differences between diets as determined by one-way ANOVA
with Tukey and Duncan's comparison test (P < .05). CFO, commercial fish and
vegetable oil feed; EFO, enhanced fish and vegetable oil feed; TCO, transgenic
Camelina oil feed.
1 Total saturated includes 15:0, 20:0, 22:0 and 24:0.
2 Total monounsaturated includes 16:1n-9,17:1, 20:1n-11, 20:1n-7, 22:1n-9
and 24:1n-9.
3 Total n-6 PUFA includes 20:3n-6 and 22:4n-6.
4 Total n-3 PUFA includes 20:3n-3.
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EFO > TCO > CFO (Fig. 3B). The expression levels of fatty acid
binding protein (fabp1) were also up-regulated in the liver of fish fed
EFO (Fig. 3C), with no difference observed for the same gene in anterior
intestine (Fig. 3D). There were no significant differences in expression
of fatty acid synthase (fas) in liver (Fig. 3E) or anterior intestine
(Fig. 3F), although expression was numerically lowest in fish fed TCO in
both tissues.
3.3.3. Transcription factors
As observed with fas, although there were no significant differences
in expression of sterol regulatory element binding protein 1 (srebp1) in
liver (p = .256; Fig. 4A) or anterior intestine (p = .256; Fig. 4B), ex-
pression was numerically lowest in fish fed TCO in both tissues. This
pattern was also observed for expression of srebp2 in anterior intestine
(Fig. 4D), but expression of srebp2 in liver was significantly lower in fish
fed EFO compared to fish fed CFO, with expression level intermediate in
fish fed TCO tissue (Fig. 4C). There was no significant dietary regulation
of peroxisome proliferator active receptor α (pparα) in either tissue,
although highest expression in liver was observed in fish fed diet TCO
(Fig. 4E), whereas expression in anterior intestine was numerically
highest in fish fed diet EFO (Fig. 4F).
4. Discussion
Sustainable growth of aquaculture requires new, scalable sources of
DHA and EPA that can improve the declining n-3 LC-PUFA content of
commercial feeds and, at the same time, do not compromise growth or
feed efficiency. Genetic modification of oilseed crops can provide viable
and feasible new sources of EPA and DHA for fish feeds to supplement
the finite supply of FO (Tocher et al., 2019). In the present study, the
impacts of an oil derived from GM-Camelina sativa plants containing
both EPA and DHA on growth performance, feed efficiency, fatty acid
profile and metabolic gene expression was evaluated in European sea
bass for first time. In particular, a diet containing the de novo oil (TCO)
was benchmarked against a commercial feed formulation (CFO) and a
feed formulated with conventional ingredients and enhanced levels of
EPA and DHA from fish oil (EFO). Results were promising, showing that
the inclusion of TCO did not impact on any of the performance para-
meters evaluated, confirming that this oil is an effective substitute for
FO in Mediterranean fish species, as previously reported for gilthead sea
bream (Betancor et al., 2016b).
Previous studies showed that one of the main adverse effects of the
complete (100%) substitution of FO by VO in carnivorous marine spe-
cies such as sea bass was reduced growth and general performance of
the fish (Geay et al., 2010, 2015; Torrecillas et al., 2016, 2017; Mu
et al., 2018). While there were no significant differences in final weight
across dietary treatments in the present study, SGR was significantly
higher in fish fed the enhanced EFO diet compared to fish fed TCO. The
reduction in SGR was positively related with feed intake (FI), with fish
fed EFO and TCO showing the highest and lowest FI, respectively, with
FI intermediate in fish fed CFO. Similarly, sea bream fed diets con-
taining another GM-derived oil with high EPA displayed slightly lower
SGR and FI than fish fed a diet containing FO or a GM-derived oil with
high EPA + DHA similar to the one used in the present trial (Betancor
et al., 2016b). However, it must be noted that in the aforementioned
Table 5
Lipid contents (% of wet weight) and fatty acid compositions (% total fatty
acids) of red blood cells of European seabass after 4 months of feeding the
experimental diets.
CFO TCO EFO
14:0 1.2 ± 0.3a 0.6 ± 0.1b 1.2 ± 0.4a
16:0 20.0 ± 1.8 19.7 ± 1.4 21.1 ± 0.8
18:0 13.2 ± 1.7 14.7 ± 1.6 13.9 ± 1.0
Total saturated1 35.5 ± 3.3 36.7 ± 2.6 37.2 ± 1.0
16:1n-7 1.8 ± 0.5a 1.0 ± 0.1b 1.9 ± 0.4a
18:1n-9 23.7 ± 4.2a 15.0 ± 1.6b 18.7 ± 6.2ab
18:1n-7 2.4 ± 0.3a 1.7 ± 0.1b 2.2 ± 0.6ab
20:1n-9 1.5 ± 0.2b 2.7 ± 0.3a 1.3 ± 0.2b
Total monounsaturated2 32.1 ± 5.3a 22.9 ± 2.0b 29.9 ± 2.1a
18:2n-6 7.1 ± 0.8b 8.3 ± 0.2a 5.9 ± 0.8b
18:3n-6 0.1 ± 0.0b 0.5 ± 0.1a 0.2 ± 0.0b
20:2n-6 0.4 ± 0.0b 0.8 ± 0.1a 0.4 ± 0.0b
20:3n-6 0.1 ± 0.0 0.3 ± 0.0 0.1 ± 0.1
20:4n-6 1.8 ± 0.5b 4.5 ± 0.4a 1.9 ± 0.1b
22:5n-6 0.2 ± 0.0a 0.1 ± 0.0b 0.2 ± 0.0a
Total n-6 PUFA3 9.9 ± 0.5b 14.7 ± 1.2a 8.9 ± 0.7b
18:3n-3 1.5 ± 0.3b 1.9 ± 0.5a 1.1 ± 0.3b
18:4n-3 0.3 ± 0.1 0.2 ± 0.1 0.3 ± 0.0
20:3n-3 n.d. 0.3 ± 0.0 0.4 ± 0.0
20:4n-3 0.1 ± 0.0b 0.5 ± 0.1a 0.2 ± 0.3b
20:5n-3 6.4 ± 1.3 5.9 ± 0.3 7.3 ± 0.5
22:5n-3 0.7 ± 0.2b 2.1 ± 0.2a 0.7 ± 0.1b
22:6n-3 12.6 ± 4.2 13.8 ± 2.2 13.0 ± 1.7
Total n-3 PUFA4 21.5 ± 5.5 24.8 ± 2.6 23.0 ± 2.4
Total n-3 LC-PUFA 19.7 ± 2.7 22.7 ± 2.6 21.7 ± 2.7
1 Total saturated includes 15:0, 20:0, 22:0 and 24:0.
2 Total monounsaturated includes 17:1, 20:1n-11, 20:1n-7, 22:1n-11, 22:1n-
9, 24:1n-9.
3 Total n-6 includes 20:3n-6 and 22:4n-6.
4 Total n-3 PUFA includes 20:3n-3.
Table 6
Lipid contents (% of wet weight) and fatty acid compositions (% total fatty




Lipid content 10.8 ± 2.4 9.5 ± 0.5 11.2 ± 2.7
Total saturated 26.8 ± 2.3 26.6 ± 0.5 26.6 ± 1.4
Total monoenes 37.2 ± 3.9a 30.8 ± 0.5b 37.0 ± 1.6a
18:2n-6 5.7 ± 2.9 6.5 ± 0.8 6.0 ± 1.6
18:3n-6 0.1 ± 0.1 0.5 ± 0.1 0.1 ± 0.0
20:2n-6 0.3 ± 0.0 0.1 ± 0.0 0.4 ± 0.1
20:4n-6 1.6 ± 0.5b 3.1 ± 0.1a 1.7 ± 0.4b
22:5n-6 0.1 ± 0.1 0.1 ± 0.0 0.1 ± 0.0
Total n-6 PUFA1 8.1 ± 2.5 10.9 ± 0.9 8.5 ± 1.4
18:3n-3 1.8 ± 1.0 2.3 ± 0.3 1.8 ± 0.5
18:4n-3 0.4 ± 0.2 0.3 ± 0.0 0.5 ± 0.2
20:4n-3 0.2 ± 0.1 0.5 ± 0.0 0.2 ± 0.1
20:5n-3 4.2 ± 0.5 3.9 ± 0.2 4.7 ± 0.7
22:5n-3 0.9 ± 0.0 1.6 ± 0.1 1.0 ± 0.1
22:6n-3 16.0 ± 4.4 17.7 ± 0.4 15.1 ± 2.2
Total n-3 PUFA2 23.4 ± 2.7 26.5 ± 0.4 23.4 ± 0.6
Total n-3 LC-PUFA 21.3 ± 3.8 23.9 ± 0.2 21.1 ± 1.3
Gill
Lipid content 8.3 ± 1.0 7.0 ± 0.2 7.4 ± 1.0
Total saturated 23.2 ± 1.1 20.8 ± 0.5 23.6 ± 0.3
Total monoenes 45.1 ± 0.8a 32.3 ± 0.9b 43.4 ± 0.6a
18:2n-6 11.5 ± 0.6b 16.5 ± 0.7a 10.9 ± 0.3b
18:3n-6 0.2 ± 0.0b 1.2 ± 0.1a 0.3 ± 0.0b
20:2n-6 0.5 ± 0.0b 1.1 ± 0.2a 0.5 ± 0.0b
20:4n-6 0.8 ± 0.1b 2.2 ± 0.2a 0.9 ± 0.1b
22:5n-6 0.2 ± 0.0 0.1 ± 0.0 0.2 ± 0.0
Total n-6 PUFA1 13.3 ± 0.6b 22.1 ± 0.7a 12.9 ± 0.4b
18:3n-3 3.6 ± 0.2b 5.8 ± 0.3a 3.2 ± 0.1b
18:4n-3 0.8 ± 0.1b 0.9 ± 0.0a 0.9 ± 0.0ab
20:4n-3 0.3 ± 0.0c 1.2 ± 0.1a 0.3 ± 0.0b
20:5n-3 5.2 ± 0.3b 5.9 ± 0.1a 6.1 ± 0.1a
22:5n-3 0.9 ± 0.1c 2.8 ± 0.1a 1.1 ± 0.1b
22:6n-3 6.5 ± 0.5b 7.3 ± 0.0a 6.9 ± 0.3ab
Total n-3 PUFA2 17.5 ± 0.9b 24.5 ± 0.6a 18.8 ± 0.4b
Total n-3 LC-PUFA 13.2 ± 0.7c 17.8 ± 0.3a 14.7 ± 0.4b
Results are means ± SEM (n = 3). Different superscript letters within a row
denote significant differences between diets as determined by one-way ANOVA
with Tukey comparison test (P < .05). CFO, commercial fish and vegetable oil
feed; EFO, enhanced fish and vegetable oil feed; TCO, transgenic Camelina oil
feed.
1 Total n-6 PUFA includes 20:3n-6 and 22:4n-6.
2 Total n-3 PUFA includes 20:3n-3.
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trial, feeds contained high levels of FM (>48%), whereas in the present
trial the diets were formulated to reflect the present standard in com-
mercial feeds with reduced FM (25%) that, in turn, could explain the
differences between the impact of the GM-derived oil with high
EPA + DHA between the two species. Several studies have shown
previously that diets lacking or with low levels of FM and/or FO may
have an adverse impact on palatability of the feed and so initially im-
pair FI (Deng et al., 2006; Fortes da Silva et al., 2010; Luz et al., 2018).
Indeed, FI and SGR were only lower in fish fed TCO in the first month of
the study and after that, there were no significant differences. What was
also clear in the present trial is that the initial differences in FI, po-
tentially due to reduced palatability, can be overcome as demonstrated
by the lack of difference in FI for the overall trial among fish fed the
different dietary treatments. In agreement, a study investigating vo-
luntary food intake demonstrated a greater preference for FO-based
diets compared to VO diets in juvenile rainbow trout but largely at the
start of the trial (Geurden et al., 2005). Additionally, Brassicaceae, such
as Camelina sativa, are known to be contain glucosinolates (Berhow
et al., 2013), which are responsible for the bitter or sharp taste of many
cruciferous vegetables (Clarke, 2010). In this respect, studies with in-
gredients rich in glucosinolates have shown reduced growth due to
negative palatability (Francis et al., 2001), which may support the
observation of lower SGR in fish fed the TCO diet due likely to initially
lower palatability of that feed. However, FI in fish fed the TCO diet
surpassed numerically FI in fish fed the CFO diet at the end of the trial
(40.2 ± 1.9 and 39.8 ± 1.2 g tank−1, respectively), suggesting that
issues of negative palatability were transient and could potentially be
avoided if glucosinolate level was reduced or specific attractants were
added to the feed. The biotechnological reduction of glucosinolates in
C. sativa is a logical and tractable target for future manipulation (Nour-
Eldin et al., 2017).
As expected, the tissue fatty acid profiles mirrored those of the diets,
at the same time reflecting the specific metabolic/physiological func-
tions of each tissue. In this sense, the fatty acid composition of the brain
was the most conserved and less affected by diet, with the highest DHA
content (16.3% on average). The relevance that DHA has for neural
function and that DHA-deficient diets can lead to visual and beha-
vioural alterations is widely known (Bell and Tocher, 1989; Benítez-
Santana et al., 2012), explaining why DHA is selectively retained in
brain to maintain vital neural functions. Indeed, the conserved fatty
acid composition of brain in the present trial was in agreement with
previous studies in different anadromous and marine fish species
(Brodtkorb et al., 1997; Bell et al., 1999; Benedito-Palos et al., 2010;
Betancor et al., 2014, 2016b; Rombenso et al., 2016), indicating the
robustness of this tissue to dietary changes in lipid source. A common
aspect in all the evaluated tissues, was the presence of significantly
higher levels of ARA in fish fed TCO. ARA is an essential fatty acid for
fish and inadequate levels can impact on fish growth and performance
(Norambuena et al., 2015; Torrecillas et al., 2018; Chee et al., 2020).
Additionally, ARA plays a key role in initiating inflammatory responses
both in humans (Tallima and El Ridi, 2018) and fish (Li et al., 2012;
Dantagnan et al., 2017), mediated through their potent bioactive ei-
cosanoid products (Calder, 2009). Nonetheless, other C20 PUFA, such as
EPA, are known to modulate eicosanoid metabolism by both inhibiting
the conversion of ARA to eicosanoids as well as by being converted to
eicosanoids with different, often milder, activity compared to their ARA
homologues (Weber, 1990). In the present trial, the higher tissue levels
of ARA in TCO-fed fish were compensated by increased deposition of
both EPA and 20:4n-3. Indeed, all the tissues of fish fed TCO displayed
increased levels of the latter fatty acid, and it is known that supple-
mentation of rainbow trout macrophages with 20:4n-3 decreased the
conversion of ARA into prostaglandins, while 20:4n-3 was simulta-
neously converted into eicosanoids with ARA-antagonising properties
(Samel et al., 1987; Ghioni et al., 2004). In the present trial, the level of
20:4n-3 was at least double in fish fed TCO than in those of the other
treatments, with a 6-fold increase in the case of liver, which could
potentially compensate for the higher ARA levels, maintaining a ba-
lanced production of pro- and anti-inflammatory lipid mediators.
Inclusion of the oil derived from the GM oilseed crop promoted the
deposition of the health beneficial fatty acids EPA and DHA in the flesh
of sea bass at levels comparable to fish fed the commercial standard
(CFO) and n-3 LC-PUFA enhanced (EFO) diets that were formulated
with fish oil. Sea bass is regarded as a lean fish, accumulating low levels
of fat in their muscle, as observed in the present trial (~4% on average)
and, as expected, closely mirroring the fatty acid profile of the diets
(Betancor et al., 2016b; Bordignon et al., 2020). In addition, the flesh of
fish fed TCO displayed levels of n-3 docosapentaenoic acid (DPA; 22:5n-
3) > 2-fold higher than those fed the other two diets. The n-3 DPA
may play a role in imparting the health benefits previously attributed
solely to EPA and DHA (Drouin et al., 2019) and thus the higher level of
this fatty acid in flesh of fish fed TCO might offer enhanced health
benefits compared to fish fed the other diets. Of course, it must be ac-
knowledged that the experimental fish were not of harvest size and that
lipid and fatty acid deposition may vary with fish size as has been de-
monstrated previously (Salini et al., 2016; Ren et al., 2017). Red blood
cells (RBC) have been acknowledged as a good proxy for flesh fatty acid
profile, at least in Atlantic salmon (Schlechtriem et al., 2009). In the
present study, the fatty acid compositions of RBC and flesh were
Table 7
Lipid content (% of wet weight) and total lipid fatty acid composition (% total
fatty acids) of anterior intestine and head kidney of European seabass after
4 months of feeding the experimental diets.
CFO TCO EFO
Anterior intestine
Lipid content 7.2 ± 0.8 5.6 ± 0.2 6.0 ± 0.9
Total saturated 23.3 ± 0.8b 22.6 ± 0.6b 25.5 ± 1.2a
Total monoenes 41.0 ± 0.5a 27.2 ± 1.7c 37.1 ± 1.2b
18:2n-6 12.4 ± 0.7b 15.9 ± 0.8a 10.6 ± 1.1b
18:3n-6 0.2 ± 0.0 1.1 ± 0.0 0.2 ± 0.0
20:2n-6 0.5 ± 0.1 1.1 ± 0.0 0.6 ± 0.0
20:4n-6 1.3 ± 0.1b 3.5 ± 0.3a 1.6 ± 0.2b
22:5n-6 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.0
Total n-6 PUFA1 14.7 ± 0.6b 22.6 ± 1.0a 13.8 ± 0.8b
18:3n-3 3.8 ± 0.3b 5.3 ± 0.3a 3.0 ± 0.4b
18:4n-3 0.7 ± 0.1 0.8 ± 0.0 0.7 ± 0.1
20:4n-3 0.3 ± 0.1b 1.0 ± 0.0a 0.3 ± 0.0b
20:5n-3 6.0 ± 0.2b 6.4 ± 0.3ab 7.0 ± 0.2a
22:5n-3 0.9 ± 0.1c 2.7 ± 0.0a 1.1 ± 0.0b
22:6n-3 8.1 ± 0.5b 10.2 ± 0.4a 10.2 ± 1.0a
Total n-3 PUFA2 20.1 ± 0.3c 27.1 ± 0.8a 22.6 ± 0.8b
Total n-3 LC-PUFA 15.5 ± 0.5c 21.0 ± 0.6a 18.9 ± 1.2b
Head kidney
Lipid content 13.3 ± 0.4a 9.7 ± 1.1b 8.1 ± 1.3b
Total saturated 24.2 ± 0.4 26.2 ± 2.9 28.9 ± 2.4
Total monoenes 47.0 ± 0.8a 36.0 ± 1.5b 46.9 ± 2.6a
18:2n-6 11.7 ± 0.4b 16.3 ± 0.8a 10.2 ± 0.9b
18:3n-6 0.2 ± 0.0b 1.0 ± 0.1a 0.2 ± 0.0b
20:2n-6 0.5 ± 0.0 1.1 ± 0.0 0.5 ± 0.1
20:4n-6 0.5 ± 0.1b 1.6 ± 0.1a 0.6 ± 0.2b
22:5n-6 0.1 ± 0.0 0.1 ± 0.1 0.1 ± 0.1
Total n-6 PUFA1 13.1 ± 0.5b 20.8 ± 1.1a 11.6 ± 1.3b
18:3n-3 3.5 ± 0.0b 4.9 ± 0.6a 2.5 ± 0.4c
18:4n-3 0.7 ± 0.0 0.6 ± 0.1 0.6 ± 0.1
20:4n-3 0.3 ± 0.0b 0.8 ± 0.2a 0.2 ± 0.0b
20:5n-3 4.5 ± 0.2 3.9 ± 0.9 3.9 ± 1.1
22:5n-3 0.7 ± 0.0b 1.8 ± 0.4a 0.6 ± 0.2b
22:6n-3 4.8 ± 0.3 4.0 ± 1.2 3.6 ± 1.5
Total n-3 PUFA2 14.8 ± 0.6 16.6 ± 3.4 11.6 ± 3.4
Total n-3 LC-PUFA 10.6 ± 0.5 11.1 ± 2.7 8.5 ± 2.9
Results are means ± SEM (n = 3). Different superscript letters within a row
denote significant differences between diets as determined by one-way ANOVA
with Tukey comparison test (P < .05). CFO, commercial fish and vegetable oil
feed; EFO, enhanced fish and vegetable oil feed; TCO, transgenic Camelina oil
feed.
1 Total n-6 PUFA includes 20:3n-6 and 22:4n-6.
2 Total n-3 PUFA includes 20:3n-3.
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generally similar, showing the same patterns in both n-6 and n-3 LC-
PUFA, with similar levels of DHA among fish fed the different dietary
treatments. In agreement, studies have found that DHA levels in RBC
were relatively stable, even when fish were fed diets poor in n-3 LC-
PUFA (Waagbø et al., 1993, 1995; Montero et al., 2003).
In contrast, liver and anterior intestine are known to be two of the
most active metabolic tissues in fish (Tocher, 2003; Betancor et al.,
2016a). This can be corroborated in view of the present results, as both
tissues presented differences in the levels of EPA and DHA among fish
fed the different diets, with fish fed TCO exhibiting the highest levels in
the case of liver, whereas fish fed TCO and EFO showed similar levels of
DHA in the intestine. The expression of genes of LC-PUFA biosynthesis
in these target tissues in part supported this hypothesis, showing up-
regulation of elovl5 expression in liver and, particularly, anterior in-
testine of fish fed TCO. In contrast, the relative expression levels of
fads2 were similar among fish fed all the dietary treatments. Although
this desaturase is generally considered to be the rate-limiting step in the
LC-PUFA biosynthesis pathway (Vagner and Santigosa, 2011), it is
known that fads2 is barely functional in seabass (González-Rovira et al.,
2009), which might explain the lack of nutritional regulation. However,
it is important to note that, in the present study, there is no negative
control diet with low LC-PUFA levels (e.g. VO alone) and that the
dietary levels of EPA + DHA in all feeds were well above requirements.
This also might explain why no differences were observed in the ex-
pression of fads2 in contrast to results obtained with other marine
species where this gene was up-regulated in fish fed low levels of LC-
PUFA (Izquierdo et al., 2008; Betancor et al., 2016b; Houston et al.,
2017; Jin et al., 2017). Surprisingly, another tissue that did not entirely
reflect dietary fatty acid profiles was gill, where fish fed TCO exhibited
the highest total n-3 LC-PUFA levels. Gills constitute one of the first
physical barrier defences of fish, playing a pivotal role in
osmoregulation (Bell et al., 1996), and dietary interventions often lead
to alteration of the fatty acid profile. In a previous study in sea bream,
some indication of LC-PUFA biosynthesis was observed in fish fed a GM-
derived Camelina oil with high EPA level (Betancor et al., 2016b), and
another study demonstrated dietary regulation of fads2d5 in Atlantic
salmon gills, particularly in response to ARA and EPA levels (Betancor
et al., 2014). Therefore, in future studies, it would be interesting to
evaluate the impact that feeds containing these de novo oils have, not
only on gill composition, but also on their molecular response.
Gene expression in the target tissues liver and anterior intestine was
used as an indicator of metabolic effects of diet with the focus on lipid
and energy metabolism and their transcriptional regulation. Modest
dietary regulation in these pathways was observed in liver, but no
significant differences were detected in intestine other than for elovl5.
Regarding transcription factors, liver of fish fed the standard commer-
cial diet showed up-regulation of srebp-2, whose activity is controlled
by cellular cholesterol status (Horton et al., 2003). Indeed, Srebp-2
regulates the expression of genes involved in cholesterol synthesis (Jeon
and Osborne, 2012; Carmona-Antoñanzas et al., 2014) and is up-regu-
lated in response to reduced cholesterol in fish (Minghetti et al., 2011;
Carmona-Antoñanzas et al., 2014). However, the expression levels of
srebp2 in liver in the present study did not reflect the level of dietary
FO, which, in turn, is a proxy for dietary cholesterol as FO contains
cholesterol, whereas VO do not (Gunstone and Harwood, 2007). It
should be noted, however, that on top of being devoid of cholesterol,
VO can be rich in phytosterols that can reduce plasma cholesterol in
mammals (Moreau et al., 2002), although this may not be the case in
fish (Liland et al., 2013; van Spankeren et al., 2019). Regardless, srebp2
was up-regulated in salmon when fed diets with a high phytoster-
ol:cholesterol ratio (Liland et al., 2013). Although dietary sterol levels
were not determined in the present trial, it can be speculated that the
Fig. 2. Expression of genes of long-chain polyunsaturated fatty acid (LC-PUFA) biosynthesis in (A and C) liver and (B and D) anterior intestine of European seabass as
determined by qPCR. Results are normalized expression ratios (mean ± standard error; n = 6). Different superscript letters denote differences in expression as
determined by one-way ANOVA (p < .05). Diets contained either commercial fish oil (CFO), transgenic Camelina sativa oil (TCO), or fish oil at an enhanced DHA and
EPA level (EFO). elovl5, fatty acid elongase 5; fads2, fatty acyl desaturase 2.
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rapeseed oil used in the formulation of CFO, contained higher levels of
phytosterols, that in turn lead to the up-regulation of srebp2, because
rapeseed oil is known to contain relatively high levels of phytosterols,
compared to other commonly used VO (Yang et al., 2019).
On the other hand, there was increased expression of the lipid
catabolic gene cpt1a in sea bass fed EFO compared to CFO, while TCO-
fed fish displayed intermediate values. Up-regulation of cpt1 is a
common finding when fish are fed high dietary lipid or n-3 LC-PUFA
(Peng et al., 2014; Xiao et al., 2017), which was in agreement with the
present study, as levels of dietary n-3 LC-PUFA were varied between
CFO, and the TCO and EFO. Another gene in the liver regulated by diet
was the fatty acid transporter, fabp1, which was up-regulated in fish fed
EFO. Previous studies have described a correlation between β-oxidation
capacity and expression levels of fabps in fish (Londraville and Sidell,
1996; Torstensen et al., 2009), which was consistent with the results of
the present study as indicated by the expression patterns of cpt1a and
fabp1 in liver.
The present study has contributed new information supporting the
efficacy of GM Camelina oil as a replacement for FO in feeds for
European seabass. Fish fed the GM-derived oil grew equally to fish fed
either a standard commercial diet or one with enhanced levels of
EPA + DHA. Slightly reduced growth of fish fed TCO at the beginning
of the trial was related to lower feed intake, possibly caused by glu-
cosinolates in Camelina sativa, but was transient and disappeared after
the first month of feeding. The GM-derived oil improved the nutritional
quality of the fish fillet, enhancing total n-3 PUFA level compared to
Fig. 3. Expression of lipid metabolism genes in liver (A, C and E) and anterior intestine (B, D and F) of European seabass as determined by qPCR. Results are
normalized expression ratios (mean ± standard error; n = 6). Different superscript letters denote differences in expression as determined by one-way ANOVA
(p < .05). Diets contained either commercial fish oil (CFO), transgenic Camelina sativa oil (TCO), or fish oil at an enhanced DHA and EPA level (EFO). cpt1a,
carnitine palmitoyltransferase 1A; fapb1, fatty acid binding protein 1; fas, fatty acid synthase.
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fish fed the other two diets. The small changes in dietary LC-PUFA did
not trigger a strong and consistent response from a molecular point of
view, while there were indications of endogenous production of LC-
PUFA in tissues such as liver, intestine and gill. The high levels of LC-
PUFA present in TCO and EFO appeared to trigger a metabolic response
consisting of an up-regulation of both β-oxidation (cpt1a) and fatty acid
transport (fabp1). The present study corroborates that oils derived from
GM crops are an excellent source of EPA and DHA and thus a substitute
for FO in diets for marine carnivorous species, helping to fill the gap
between supply and demand for n-3 LC-PUFA.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.aquaculture.2020.735759.
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